| Title |
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2006
|
| DOI | 10.1002/14651858.cd003967.pub2 |
| Pubmed ID | |
| Authors |
Giovanni FM Strippoli, Sankar D Navaneethan, Jonathan C Craig, Suetonia C Palmer |
| Abstract |
Anaemia affects 60% to 80% of patients with chronic kidney disease (CKD) reduces quality of life and is a risk factor for early death. Treatment options are blood transfusion, erythropoietin (EPO) and darbepoetin alfa. Recently higher haemoglobin (Hb) and haematocrit (HCT) targets have been widely advocated because of positive associations with improved survival and quality of life from observational studies. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 184 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 2 | 1% |
| United States | 1 | <1% |
| Brunei Darussalam | 1 | <1% |
| Italy | 1 | <1% |
| Unknown | 179 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 11% |
| Student > Master | 18 | 10% |
| Student > Bachelor | 18 | 10% |
| Student > Ph. D. Student | 13 | 7% |
| Student > Postgraduate | 10 | 5% |
| Other | 38 | 21% |
| Unknown | 67 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 63 | 34% |
| Nursing and Health Professions | 16 | 9% |
| Unspecified | 7 | 4% |
| Social Sciences | 6 | 3% |
| Agricultural and Biological Sciences | 5 | 3% |
| Other | 17 | 9% |
| Unknown | 70 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2023.
All research outputs
#3,267,716
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#5,896
of 11,499 outputs
Outputs of similar age
#7,657
of 84,801 outputs
Outputs of similar age from Cochrane database of systematic reviews
#19
of 71 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 84,801 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.